DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Stereotaxis, Inc. (STXS)
« Back to company indexSTXS Chatter Timeline
Stock Ticker for STXS
Most Active Tweeters for STXS
| User | Tweets |
|---|---|
| @ErikaWeis1 | 11 |
| @Gambiste1 | 6 |
| @Berserker7 | 2 |
| @fintel_io | 2 |
| @Briefingcom | 1 |
Recent Tweets for STXS
 |
@Berserker7 @Sarahkatilyn I wasn’t able to say good morning and see if ya watched $STXS pop it’s head into the $3. Said I could… https://t.co/RqFJAG1eOF March 27th 2020, 4:03pm |
 |
@bUrRpPPP $STXS $2.75 Jumped back in the this growing medical technology co that just got FDA clearance that has gone under a… https://t.co/YeJWl4l0Cz March 25th 2020, 5:03pm |
 |
@dispatchtribune Stereotaxis $STXS Stock Price Up 7.5% https://t.co/kN3VDNVk3X March 24th 2020, 11:03am |
|
@Berserker7 $STXS WTF is goin on Here? https://t.co/Qcauvnwpp6 March 18th 2020, 12:03pm |
 |
@Gambiste1 RT @ErikaWeis1: “The highlight of the past year was the significant progress made in our innovation and collaboration strategy. $STXS March 18th 2020, 12:03am |
|
@Gambiste1 RT @ErikaWeis1: Thirty-four peer-reviewed scientific papers were published on Stereotaxis robotic technology. $STXS March 18th 2020, 12:03am |
|
@Gambiste1 RT @ErikaWeis1: Listed Stereotaxis’ common stock on the NYSE American Exchange. $STXS March 18th 2020, 12:03am |
|
@Gambiste1 RT @ErikaWeis1: Raised $25 million in a private placement from select healthcare and growth oriented institutional investors. $STXS March 18th 2020, 12:03am |
|
@Gambiste1 RT @ErikaWeis1: “We are excited for the coming year and pleased with the momentum with which we have begun 2020. $STXS March 18th 2020, 12:03am |
|
@Gambiste1 RT @ErikaWeis1: Stereotaxis Reports 2019 Full Year Financial Results $STXS March 18th 2020, 12:03am |
 |
@ErikaWeis1 These forecasts include the currently predicted impact of coronavirus COVID-19. $STXS March 18th 2020, 12:03am |
|
@ErikaWeis1 Robotic system orders are expected to provide confidence in revenue growth sustaining and potentially accelerating in 2021 and beyond. $STXS March 18th 2020, 12:03am |
|
@ErikaWeis1 Operating expenses are expected to moderately increase in 2020. $STXS March 18th 2020, 12:03am |
|
@ErikaWeis1 Cash Balance and Liquidity At December 31, 2019, Stereotaxis had cash and cash equivalents of $30.2 million and no debt. $STXS March 18th 2020, 12:03am |
|
@ErikaWeis1 “The highlight of the past year was the significant progress made in our innovation and collaboration strategy. $STXS March 17th 2020, 11:03pm |
|
@ErikaWeis1 Implemented broad integration with advanced preoperative mapping technologies from ADAS 3D, inHeart, and Catheter Precision. $STXS March 17th 2020, 11:03pm |
|
@ErikaWeis1 Thirty-four peer-reviewed scientific papers were published on Stereotaxis robotic technology. $STXS March 17th 2020, 11:03pm |
|
@ErikaWeis1 Listed Stereotaxis’ common stock on the NYSE American Exchange. $STXS March 17th 2020, 11:03pm |
|
@ErikaWeis1 Raised $25 million in a private placement from select healthcare and growth oriented institutional investors. $STXS March 17th 2020, 11:03pm |
|
@ErikaWeis1 “We are excited for the coming year and pleased with the momentum with which we have begun 2020. $STXS March 17th 2020, 11:03pm |
|
@ErikaWeis1 Stereotaxis Reports 2019 Full Year Financial Results $STXS March 17th 2020, 11:03pm |
 |
@Briefingcom $STXS: Stereotaxis files for $100 mln mixed securities shelf offering https://t.co/1Ztbk1MZyV March 16th 2020, 6:03pm |
 |
@fintel_io $STXS / Stereotaxis files form S-3 https://t.co/xsASDnH26X March 16th 2020, 4:03pm |
 |
@Stock_News_Now $STXS: New SEC Filing for STXS: Form 10-K (No. 0001493152-20-004012): https://t.co/larHue8IVL March 16th 2020, 4:03pm |
|
@fintel_io $STXS / Stereotaxis files form 10-K https://t.co/xsASDnH26X March 16th 2020, 3:03pm |
|
@dispatchtribune InMode $INMD and Stereotaxis $STXS Head to Head Review https://t.co/chWh7Yz6XI March 13th 2020, 4:03am |
|
@Berserker7 $STXS what happened hear? Great report yesterday and no one wants to win?!?!? More for me. Long play it is! March 11th 2020, 1:03pm |
 |
@SwingTradeBot Fell Below 50 DMA today: $STXS ... https://t.co/j2lcQOTpfA March 11th 2020, 10:03am |
 |
@ChartMill In the last month $STXS has a been trading in the 3.17 - 5.00 range, which is quite wide. https://t.co/7mExrvODlA https://t.co/w8lqYp34Wf March 10th 2020, 10:03pm |
 |
@newsfilterio Stereotaxis reports Q4 results $STXS https://t.co/Som4cFKH1p March 10th 2020, 10:03pm |
|
@Berserker7 $STXS Huge Cash Reserve, no debt, huge 2019 profits with confirmed sales, Incredible 2020 Forecast, new catheter pr… https://t.co/HOu6OSUIZp March 10th 2020, 3:03pm |
 |
@SiteFocusHQ $STXS Earnings Intelligence Analysis of recent earnings identified Stereotaxis, Inc. (STXS) business focus on (cath… https://t.co/Veso5ta61Y March 10th 2020, 2:03pm |
 |
@SeekingAlpha $STXS - Stereotaxis, Inc. (STXS) CEO David Fischel on Q4 2019 Results - Earnings Call Transcript.… https://t.co/w2VLV12X46 March 10th 2020, 2:03pm |
 |
@GambisteFinance $STXS is today ranked #6 in Gambiste Small Cap. Is there something new regarding Stereotaxis, Inc. Common Stock ? C… https://t.co/50phBHzari March 10th 2020, 2:03pm |
 |
@StockNewsNow $STXS Stereotaxis Reports 2019 Full Year Financial Results https://t.co/jhtB4QqeFy March 10th 2020, 1:03pm |
 |
@AlertTrade UP WITH EARNINGS TODAY ALERT: $STXS Stereotaxis, Inc. ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room March 10th 2020, 9:03am |
|
@Stock_News_Now $STXS: New SEC Filing for STXS: Form 8-K (No. 0001493152-20-003643): https://t.co/G1l61647zp March 10th 2020, 9:03am |
 |
@otcdynamics $STXS Stereotaxis Reports 2019 Full Year Financial Results https://t.co/zVJN9lNEVS March 10th 2020, 8:03am |
 |
@StockTexts $STXS Stereotaxis, Inc. SEC Filing: Form 8-K https://t.co/mUWtpo3jnT March 10th 2020, 8:03am |
|
@fintel_io $STXS / Stereotaxis files form 8-K - Results of Operations and Financial Condition, Financial Statements and Exhibi… https://t.co/NprExWUPN1 March 10th 2020, 8:03am |
 |
@StckPro $STXS NEW ARTICLE : Stereotaxis reports Q4 results https://t.co/SVXgaJkBDw March 10th 2020, 8:03am |
 |
@MarketCurrents $STXS - Stereotaxis reports Q4 results https://t.co/mFvAhPBi7a March 10th 2020, 8:03am |
 |
@AccesswireNews $STXS Stereotaxis, Inc. to Host Earnings Call https://t.co/S22su3gTVc March 10th 2020, 8:03am |
 |
@AJohnsonShow $STXS ? March 10th 2020, 6:03am |
|
@newsfilterio Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System $STXS https://t.co/ZNiivCcZuZ March 10th 2020, 4:03am |
|
@GambisteFinance $STXS is today ranked #1 in Gambiste Small Cap. Is there something new regarding Stereotaxis, Inc. Common Stock ? C… https://t.co/nwNlTw2JTE March 10th 2020, 2:03am |
|
@ErikaWeis1 Across a broad range of navigational routines, the Genesis System is 70% to 80% faster than its predecessor. $STXS March 9th 2020, 10:03pm |
|
@ErikaWeis1 Genesis is a reflection of our commitment to positively transform interventional medicine with robotics.” $STXS March 9th 2020, 10:03pm |
|
@ErikaWeis1 Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System $STXS March 9th 2020, 10:03pm |
|
@ErikaWeis1 https://t.co/vbgO2iGnuc $STXS March 9th 2020, 10:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.